William Blair Downgrades Anadys Pharmaceuticals (ANDS) to Market Perform

William Blair downgraded Anadys Pharmaceuticals (NASDAQ: ANDS) from Outperfrom to Market Perform, maintains price target of $4.00.

For an analyst ratings summary and ratings history on Anadys Pharmaceuticals click here. For more ratings news on Anadys Pharmaceuticals click here.

Shares of Anadys Pharmaceuticals closed at $3.64 yesterday, with a 52 week range of $0.60-$3.69.

---

Discover Wall Street's best ratings calls with the pros - Upgrade to Ratings Insider Elite. Free Trial!

You May Also Be Interested In

• UPDATE: UBS Downgrades Wisconsin Energy (WEC) to Neutral; Taking Some Off The Table
• Canaccord Genuity Maintains a 'Hold' on Tiffany & Co. (TIF); Cutting PT and Estimates
• Barclays Lowers PT and Estimates on Royal Bank of Canada (RY); Coming Off The Bandwagon

Create E-mail Alert Related Categories

Downgrades

Related Entities

William Blair

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?

Follow StreetInsider.com On Twitter